ARBs to be tested over contamination concerns

The move from the TGA follows the withdrawal of two valsartan brands last year

The TGA is testing a range of ARB medications for contamination following the recall of two valsartan brands last year.

Valsartan

Mylan and Apotex withdrew their valsartan products after regulators found they were contaminated with N-nitrosodiethylamine, a probable carcinogen but one that is common in cured meats or air pollution.

The contamination of these tablets was linked to manufacturers in India and China.

On Wednesday, the medicines

Latest

Trending